Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Four-year, Safety and Tolerability, Open-Label, "Follow on" Trial Evaluating Technosphere® Insulin in Subjects With Type 2 Diabetes Mellitus.

NCT00754624 is registered in ClinicalTrials.gov with Mannkind Corporation as lead sponsor.

NCT NCT00754624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00754624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Four-year, Safety and Tolerability, Open-Label, "Follow on" Trial Evaluating Technosphere® Insulin in Subjects With Type 2 Diabetes Mellitus.
Lead sponsor
Mannkind Corporation
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
October 31, 2008
Enrollment
229 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus